↓ Skip to main content

Development of Chromosome 1q+ Specific Treatment for Highest Risk Pediatric Posterior Fossa Ependymoma.

Overview of attention for article published in Clinical Cancer Research, February 2024
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Readers on

mendeley
2 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Development of Chromosome 1q+ Specific Treatment for Highest Risk Pediatric Posterior Fossa Ependymoma.
Published in
Clinical Cancer Research, February 2024
DOI 10.1158/1078-0432.ccr-23-3156
Pubmed ID
Authors

Andrea M Griesinger, Annaliese J Calzadilla, Enrique Grimaldo, Andrew M Donson, Vladimir Amani, Angela M Pierce, Jenna Steiner, Soudabeh Kargar, Natalie J Serkova, Kelsey C Bertrand, Karen D Wright, Rajeev Vibhakar, Todd Hankinson, Michael Handler, Holly B Lindsay, Nicholas K Foreman, Kathleen Dorris

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 2 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 1 50%
Researcher 1 50%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 1 50%
Neuroscience 1 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2024.
All research outputs
#15,338,507
of 25,746,891 outputs
Outputs from Clinical Cancer Research
#10,145
of 13,302 outputs
Outputs of similar age
#137,467
of 347,729 outputs
Outputs of similar age from Clinical Cancer Research
#54
of 86 outputs
Altmetric has tracked 25,746,891 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,302 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 347,729 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 86 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.